Trial Profile
Randomized, two arm, controlled study to compare the efficacy of oral ibandronate treatment versus intravenous zoledronate in patients with symptomatic Multiple Myeloma.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2020
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary) ; Zoledronic acid
- Indications Bone metastases; Fracture
- Focus Therapeutic Use
- Sponsors Roche
- 12 May 2011 New trial record